Dr. Patrick Hauswirth

ZHAW School of Life Sciences and Facility Management
Section for Pharmaceutical Technology and Pharmacology
Einsiedlerstrasse 31
8820 Wädenswil

+41 (0) 58 934 51 90
patrick.hauswirth@zhaw.ch

Personal profile

Position at the ZHAW

www.zhaw.ch/de/lsfm/institute-zentren/icbt/pharmazeutische-wirkstoffforschung-und-arzneimittelentwicklung/pharmazeutische-technologie-und-pharmakologie/

Publications before appointment at the ZHAW

Hauswirth, P.; Graber, P.; Buczak, K.; Mancuso, R.V.; Schenk, S.H.; Nüesch, J.P.F.; Huwyler, J. Design and Characterization of Mutated Variants of the Oncotoxic Parvoviral Protein NS1. Viruses 2023, 15, 209. doi.org/10.3390/v15010209

Pratsinis A, Uhl P, Bolten JS, Hauswirth P, Schenk SH, Urban S, Mier W, Witzigmann D, Huwyler J. Virus-Derived Peptides for Hepatic Enzyme Delivery. Mol Pharm. 2021 May 3;18(5):2004-2014. doi.org/10.1021/acs.molpharmaceut.0c01222

Witzigmann D, Grossen P, Quintavalle C, Lanzafame M, Schenk SH, Tran XT, Englinger B, Hauswirth P, Grünig D, van Schoonhoven S, Krähenbühl S, Terracciano LM, Berger W, Piscuoglio S, Quagliata L, Rommelaere J, Nüesch JPF, Huwyler J. Non-viral gene delivery of the oncotoxic protein NS1 for treatment of hepatocellular carcinoma. J Control Release. 2021 Jun 10;334:138-152. doi.org/10.1016/j.jconrel.2021.04.023

go back